APYX vs USB · rev $48.1M vs P/E 12, rev $28.66B
Apyx Medical Inc (APYX) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
APYX currently screens at market cap $179.6M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the APYX and USB stock pages for the full models.
Not investment advice.